Home / ATRA : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ATRA make money? Does ATRA have pricing power? What's the Earnings Whisper? Will ATRA profit more as the business scales? What is ATRA's management track record? Is ATRA's current price justified?

Atara Biotherapeutics, Inc.

$9.25 -$8.52 (-47.95%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$9.38

Day Range

$9.09$9.66

Year Range

$3.92$19.14

Market Cap

83.34M

AVG Volume

1.43M

Trailing/Forward PE

-7.84/9.83

PEG ratio

0.03

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

NASDAQ

Revenue (USD)

ATRA Revenue (USD) by year
Period	Revenue (USD)
2025	120.77M
2024	128.94M
2023	8.57M
2022	63.57M
2021	20.34M
2020	0
2019	0
2018	0
2017	0
2016	0

Net Income (USD)

ATRA Net Income (USD) by year
Period	Net Income (USD)
2025	32.69M
2024	-85.4M
2023	-276.13M
2022	-228.3M
2021	-340.14M
2020	-306.62M
2019	-2.2B
2018	-2.31B
2017	-1.19B
2016	-790.49M

Operating Income (USD)

ATRA Operating Income (USD) by year
Period	Operating Income (USD)
2025	35.86M
2024	-83.44M
2023	-269.32M
2022	-280.51M
2021	-340.46M
2020	-309.05M
2019	-295.68M
2018	-237.11M
2017	-121.53M
2016	-81.24M

EBITDA (USD)

ATRA EBITDA (USD) by year
Period	EBITDA (USD)
2025	38.63M
2024	-75.75M
2023	-266M
2022	-217.39M
2021	-330.68M
2020	-299.89M
2019	-288.61M
2018	-235.34M
2017	-120.58M
2016	-80.86M

Cash Flows (USD)

ATRA Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-50.94M
2024	-68.96M
2023	-194.2M
2022	-274.62M
2021	-231.1M
2020	-185.27M
2019	-241.36M
2018	-215.7M
2017	-107.73M
2016	-63.05M

EPS (USD)

ATRA EPS (USD) by year
Period	EPS (USD)
2025	3.12
2024	-12.87
2023	-65.27
2022	-55.97
2021	-90.73
2020	-105.24
2019	-142.69
2018	-130.66
2017	-99.83
2016	-68.77

Expenses (USD)

ATRA Expenses (USD) by year
Period	Expenses (USD)
2025	63.12M
2024	191.62M
2023	270.23M
2022	344.86M
2021	371.38M
2020	311.03M
2019	301.41M
2018	273.04M
2017	141.76M
2016	84.26M

Cash & Debt (USD)

ATRA Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	8.48M
2024	42.5M
2023	51.73M
2022	242.82M
2021	371.07M
2020	500.66M
2019	259.11M
2018	309.63M
2017	166.1M
2016	255.68M

Debt ratios

ATRA Debt ratios by year
Period	Debt ratios
2025	-0.09
2024	-0
2023	-0.01
2022	0.15
2021	0.3
2020	0.51
2019	0.34
2018	0.62

Margins

ATRA Margins by year
Period	Margins
2025	82.44%
2024	83.71%
2023	-3.65%
2022	-112.25%
2021	-940.65%

Return on Capital

ATRA Return on Capital by year
Period	Return on Capital
2025	-84.9%
2024	87.79%
2023	278.27%
2022	-180.28%
2021	-121.65%
2020	-66.32%
2019	-757.72%
2018	-680.82%
2017	-671.81%
2016	-311.54%

Shares Outstanding

ATRA Shares Outstanding by year
Period	Shares Outstanding
2025	12.54M
2024	10.69M
2023	4.33M
2022	4.13M
2021	3.9M
2020	3.41M
2019	2.31M
2018	1.83M
2017	1.23M
2016	1.16M

Book Value Per Share (USD)

ATRA Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	-3.07
2024	-9.1
2023	-22.94
2022	30.68
2021	71.76
2020	135.5
2019	126.07
2018	185.06
2017	145.07
2016	219.38

Total Assets (USD)

ATRA Total Assets (USD) by year
Period	Total Assets (USD)
2025	20.23M
2024	109.1M
2023	165.5M
2022	376.42M
2021	468.13M
2020	588.12M
2019	342.94M
2018	391.84M
2017	217.78M
2016	263.91M

Employee Count

ATRA Employee Count by year
Period	Employee Count
2025	14
2024	153
2023	225
2022	334
2021	578
2020	437
2019	393
2018	311
2017	185
2016	96

PE Ratio

ATRA PE Ratio by year
Period	PE Ratio
May 26	3.2
May 26	1.88
Apr 26	1.92
Apr 26	2.02
Apr 26	1.78
Apr 26	1.91
Mar 26	1.76
Mar 26	1.88
Mar 26	3.77
Mar 26	3
Feb 26	3.14
Feb 26	2.42
Feb 26	2.58
Feb 26	2.83
Jan 26	3.01
Jan 26	3.03
Jan 26	2.63
Jan 26	7.92
Jan 26	10.3
Dec 25	10.01
Dec 25	9.95
Dec 25	10.43
Dec 25	8.31
Nov 25	8.75
Nov 25	7.93
Nov 25	7.98
Nov 25	24.86
Oct 25	31.26
Oct 25	30.5
Oct 25	31.17
Oct 25	30.16
Oct 25	30.33
Sep 25	28.92
Sep 25	25.36
Sep 25	25.51
Sep 25	27.17
Aug 25	25.36
Aug 25	25.97
Aug 25	25.87

Free Cash Flow Yield

ATRA Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-15.75%
Sep 26	-15.53%
Sep 26	-14.92%
Aug 26	-15.83%
Aug 26	-15.02%
Aug 26	-18%
Aug 26	-21.75%
Jul 26	-21.93%
Jul 26	-23.26%
Jul 26	-21.9%
Jul 26	-18.83%
Jul 26	-15.77%
Jun 26	-17.48%
Jun 26	-18.25%
Jun 26	-17.65%
Jun 26	-18.52%
May 26	-17.48%
May 26	-18.75%
May 26	-19.18%
May 26	-48.69%
May 26	-82.88%
Apr 26	-81.06%
Apr 26	-77.06%
Apr 26	-87.33%
Apr 26	-81.38%
Mar 26	-88.47%
Mar 26	-82.71%
Mar 26	-79.17%
Mar 26	-99.54%
Feb 26	-94.95%
Feb 26	-123.12%
Feb 26	-115.65%
Feb 26	-105.46%
Jan 26	-98.97%
Jan 26	-98.59%
Jan 26	-113.35%
Jan 26	-37.65%
Jan 26	-28.96%
Dec 25	-29.8%
Dec 25	-29.97%
Dec 25	-28.59%
Dec 25	-35.91%
Nov 25	-34.08%
Nov 25	-37.62%
Nov 25	-37.4%
Nov 25	-44.43%
Oct 25	-35.34%
Oct 25	-36.22%
Oct 25	-35.43%
Oct 25	-36.62%
Oct 25	-36.42%
Sep 25	-38.19%
Sep 25	-43.55%
Sep 25	-43.3%
Sep 25	-40.65%
Aug 25	-43.55%
Aug 25	-42.53%
Aug 25	-42.7%
Aug 25	-57.1%
Aug 25	-54.18%
Jul 25	-54.04%
Jul 25	-62.58%
Jul 25	-67.8%
Jul 25	-73.89%
Jun 25	-78.62%
Jun 25	-78.82%
Jun 25	-70.95%
Jun 25	-67.8%
May 25	-80.23%
May 25	-87.65%
May 25	-91.49%
May 25	-88.74%
May 25	-82.5%
Apr 25	-88.13%
Apr 25	-104.56%
Apr 25	-116.66%
Apr 25	-115.41%
Mar 25	-98.79%
Mar 25	-97.3%
Mar 25	-88.98%
Mar 25	-93.5%
Feb 25	-183.86%
Feb 25	-178.69%
Feb 25	-147.9%
Feb 25	-126.29%
Jan 25	-143.07%
Jan 25	-154.56%
Jan 25	-193.37%
Jan 25	-81.7%
Jan 25	-77.7%
Dec 24	-104.56%
Dec 24	-111.44%
Dec 24	-122.99%
Dec 24	-97.5%
Nov 24	-104.31%
Nov 24	-110.76%
Nov 24	-105.87%
Nov 24	-205.09%
Nov 24	-238.88%
Oct 24	-269.72%

Price to Sales

ATRA Price to Sales by year
Period	Price to Sales
Sep 26	22.45
Sep 26	22.77
Sep 26	23.69
Aug 26	22.33
Aug 26	23.54
Aug 26	19.63
Aug 26	5.14
Jul 26	5.1
Jul 26	4.81
Jul 26	5.11
Jul 26	5.94
Jul 26	7.09
Jun 26	6.4
Jun 26	6.13
Jun 26	6.33
Jun 26	6.04
May 26	6.4
May 26	5.96
May 26	5.83
May 26	0.87
May 26	0.51
Apr 26	0.52
Apr 26	0.55
Apr 26	0.48
Apr 26	0.52
Mar 26	0.48
Mar 26	0.51
Mar 26	0.58
Mar 26	0.46
Feb 26	0.48
Feb 26	0.37
Feb 26	0.4
Feb 26	0.44
Jan 26	0.46
Jan 26	0.47
Jan 26	0.41
Jan 26	1.22
Jan 26	1.59
Dec 25	1.54
Dec 25	1.53
Dec 25	1.61
Dec 25	1.28
Nov 25	1.35
Nov 25	1.22
Nov 25	1.23
Nov 25	0.76
Oct 25	0.96
Oct 25	0.94
Oct 25	0.96
Oct 25	0.93
Oct 25	0.93
Sep 25	0.89
Sep 25	0.78
Sep 25	0.78
Sep 25	0.83
Aug 25	0.78
Aug 25	0.8
Aug 25	0.79
Aug 25	0.59
Aug 25	0.62
Jul 25	0.62
Jul 25	0.54
Jul 25	0.5
Jul 25	0.46
Jun 25	0.43
Jun 25	0.43
Jun 25	0.48
Jun 25	0.5
May 25	0.42
May 25	0.38
May 25	0.37
May 25	0.6
May 25	0.65
Apr 25	0.61
Apr 25	0.51
Apr 25	0.46
Apr 25	0.46
Mar 25	0.54
Mar 25	0.55
Mar 25	0.6
Mar 25	0.57
Feb 25	0.51
Feb 25	0.53
Feb 25	0.64
Feb 25	0.75
Jan 25	0.66
Jan 25	0.61
Jan 25	0.49
Jan 25	1.16
Jan 25	1.22
Dec 24	0.9
Dec 24	0.85
Dec 24	0.77
Dec 24	0.97
Nov 24	0.91
Nov 24	0.85
Nov 24	0.89
Nov 24	1.11
Nov 24	0.96
Oct 24	0.85

EV/EBITDA

ATRA EV/EBITDA by year
Period	EV/EBITDA
May 26	3.86
May 26	2.74
Apr 26	2.77
Apr 26	2.86
Apr 26	2.66
Apr 26	2.77
Mar 26	2.64
Mar 26	2.74
Mar 26	4.36
Mar 26	3.77
Feb 26	3.88
Feb 26	3.33
Feb 26	3.45
Feb 26	3.64
Jan 26	3.79
Jan 26	3.79
Jan 26	3.49
Jan 26	7.55
Jan 26	9.38
Dec 25	9.15
Dec 25	9.11
Dec 25	9.48
Dec 25	7.85
Nov 25	8.19
Nov 25	7.56
Nov 25	7.59
Nov 25	9.74
Oct 25	12.33
Oct 25	12.02
Oct 25	12.3
Oct 25	11.89
Oct 25	11.96
Sep 25	11.38
Sep 25	9.94
Sep 25	10
Sep 25	10.68
Aug 25	9.94
Aug 25	10.19
Aug 25	10.15

Price to Book

ATRA Price to Book by year
Period	Price to Book
Oct 23	17.62
Oct 23	19.32
Oct 23	21.71
Oct 23	19.88
Sep 23	20.87
Sep 23	25.24
Sep 23	21.57
Sep 23	21.57
Sep 23	21.85
Aug 23	20.02
Aug 23	21.01
Aug 23	29.47
Aug 23	3.68
Jul 23	3.3
Jul 23	3.36
Jul 23	2.93
Jul 23	2.96
Jun 23	2.58
Jun 23	2.82
Jun 23	3.22
Jun 23	3.17
Jun 23	2.46
May 23	2.83
May 23	3.38
May 23	3.43
May 23	2.37
Apr 23	2.21
Apr 23	2.48
Apr 23	2.19
Apr 23	2.26
Mar 23	2.36
Mar 23	2.34
Mar 23	2.46
Mar 23	2.31
Mar 23	2.94
Feb 23	3.31
Feb 23	3.68
Feb 23	3.47
Feb 23	2.83
Jan 23	2.88
Jan 23	2.13
Jan 23	2.13
Jan 23	1.92
Dec 22	1.8
Dec 22	1.64
Dec 22	1.93
Dec 22	2.44
Dec 22	2.61
Nov 22	2.29
Nov 22	2.34
Nov 22	2.81
Nov 22	1.89
Oct 22	1.92
Oct 22	1.69
Oct 22	1.49
Oct 22	1.52
Sep 22	1.51
Sep 22	1.32
Sep 22	1.61
Sep 22	1.92
Sep 22	1.71
Aug 22	1.61
Aug 22	1.77
Aug 22	2.33
Aug 22	1.54
Jul 22	1.36
Jul 22	1.45
Jul 22	1.73
Jul 22	3.82
Jul 22	3.73
Jun 22	3.28
Jun 22	2.64
Jun 22	2.34
Jun 22	2.31
May 22	2.34
May 22	2.32
May 22	2.46
May 22	3.11
Apr 22	2.22
Apr 22	2.53
Apr 22	2.79
Apr 22	3.05
Apr 22	3.31
Mar 22	3.27
Mar 22	3.41
Mar 22	3.14
Mar 22	3.08
Feb 22	3.98
Feb 22	3.96
Feb 22	4.39
Feb 22	4.41
Jan 22	4.48
Jan 22	4.22
Jan 22	4.85
Jan 22	4.74
Dec 21	4.76
Dec 21	5.22
Dec 21	4.57
Dec 21	4.82
Dec 21	5.16

No video analysis for this stock yet. Request one from our team.

News: ATRA

businesswire.com · 12 Aug 2026

Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial results for the second quarter 2026 and business updates. “This was an important quarter for Atara. We and our partners, Pierre Fabre Pharmaceuticals (PFP), had a productive Type A meeting with the.

AI Analysis

Atara Biotherapeutics, Inc.

Video analysis: ATRA

News: ATRA

Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress

Similar companies